Inactive Instrument

Columbia Laboratories Inc. Stock Nasdaq

Equities

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Juniper Pharmaceuticals : Reports Second Quarter 2018 Financial and Operating Results	18-08-09	PR
Juniper Pharmaceuticals : Signs Definitive Agreement to be Acquired by Catalent, Inc. for $11.50 Per Share in Cash	18-07-03	PR
Juniper Pharmaceuticals : Reports First Quarter 2018 Financial and Operating Results	18-05-10	PR
Juniper Pharmaceuticals : to Report First Quarter 2018 Results on May 10, 2018	18-05-01	PR
Juniper Pharmaceuticals : Licenses Intravaginal Ring (IVR) Platform to Daré Bioscience	18-04-25	PR

18-07-03

Managers	Title	Age	Since
Steven Fasman BRD	Director/Board Member	61	18-08-13

Members of the board	Title	Age	Since
Steven Fasman BRD	Director/Board Member	61	18-08-13
James Geraghty CHM	Chairman	70	15-05-25

Sector